DEVELOPMENT OF AN ASSAY PLATFORM FOR MEASURING ENDOGENOUS KINASE ACTIVITY


Year of Award:
2016
Award Type:
R43
Project Number:
1R43CA203671-01
RFA Number:
PAR-13-327
Technology Track:
Molecular & Cellular Analysis Technologies
PI/Project Leader:
OUELLETTE, STEVEN BRADLEY
Other PI or Project Leader:
N/A
Institution:
KINASENSE, LLC
Kinase inhibitors are an effective class of targeted therapy for oncology. However, heterogeneous patient response and acquired resistance continues to be a significant clinical and economic burden. To overcome this problem drug developers are pursuing no